Market Tracker

10/20 5:16pm ET

Zimmer Biomet Holdings Inc (NYSE:ZBH)

122.35
Delayed Data
As of Oct 20
 +0.47 / +0.39%
Today’s Change
95.63
Today|||52-Week Range
133.49
+18.56%
Year-to-Date
NuVasive's TLX Interbody System Gets Expanded FDA Approval
Oct 19 / Zacks.com - Paid Partner Content
Smith & Nephew: hippy hippy shake-up
Oct 11 / FT.com - Paid Partner Content

Today’s Trading

Previous close121.88
Today’s open122.37
Day’s range121.32 - 122.83
Volume792,749
Average volume (3 months)1,351,807
Market cap$24.7B
Dividend yield0.78%
Data as of 4:01pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+96.10%
Earnings growth (this year)+3.52%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+28.11%
P/E ratio34.9
Price/Sales2.72
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
BCRC R Bard Inc+2.86+0.87%
TFXTeleflex Inc+1.07+0.44%
BSXBoston Scientific Co...+0.12+0.41%
ABMDAbiomed Inc+2.41+1.40%
Data as of 4:03pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$1.75
Annual revenue (last year)$7.7B
Annual profit (last year)$305.9M
Net profit margin3.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
Director, Chief Executive &
Financial Officer
Daniel P. Florin
Senior VP-Global Operations &
Logistics
Adrian Furey
Corporate headquarters
Warsaw, Indiana

Forecasts